These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24967968)

  • 1. Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion.
    Defour A; Van der Meulen JH; Bhat R; Bigot A; Bashir R; Nagaraju K; Jaiswal JK
    Cell Death Dis; 2014 Jun; 5(6):e1306. PubMed ID: 24967968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
    Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
    J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid accumulation in dysferlin-deficient muscles.
    Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
    Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect.
    Jaiswal JK; Marlow G; Summerill G; Mahjneh I; Mueller S; Hill M; Miyake K; Haase H; Anderson LV; Richard I; Kiuru-Enari S; McNeil PL; Simon SM; Bashir R
    Traffic; 2007 Jan; 8(1):77-88. PubMed ID: 17132147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro.
    Tanaka A; Woltjen K; Miyake K; Hotta A; Ikeya M; Yamamoto T; Nishino T; Shoji E; Sehara-Fujisawa A; Manabe Y; Fujii N; Hanaoka K; Era T; Yamashita S; Isobe K; Kimura E; Sakurai H
    PLoS One; 2013; 8(4):e61540. PubMed ID: 23626698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle Cells Fix Breaches by Orchestrating a Membrane Repair Ballet.
    Barthélémy F; Defour A; Lévy N; Krahn M; Bartoli M
    J Neuromuscul Dis; 2018; 5(1):21-28. PubMed ID: 29480214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
    Sreetama SC; Chandra G; Van der Meulen JH; Ahmad MM; Suzuki P; Bhuvanendran S; Nagaraju K; Hoffman EP; Jaiswal JK
    Mol Ther; 2018 Sep; 26(9):2231-2242. PubMed ID: 30166241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
    Cai C; Weisleder N; Ko JK; Komazaki S; Sunada Y; Nishi M; Takeshima H; Ma J
    J Biol Chem; 2009 Jun; 284(23):15894-902. PubMed ID: 19380584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
    Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle.
    Defour A; Medikayala S; Van der Meulen JH; Hogarth MW; Holdreith N; Malatras A; Duddy W; Boehler J; Nagaraju K; Jaiswal JK
    Hum Mol Genet; 2017 Jun; 26(11):1979-1991. PubMed ID: 28334824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse engineering gene network identifies new dysferlin-interacting proteins.
    Cacciottolo M; Belcastro V; Laval S; Bushby K; di Bernardo D; Nigro V
    J Biol Chem; 2011 Feb; 286(7):5404-13. PubMed ID: 21119217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.
    Chiu YH; Hornsey MA; Klinge L; Jørgensen LH; Laval SH; Charlton R; Barresi R; Straub V; Lochmüller H; Bushby K
    Hum Mol Genet; 2009 Jun; 18(11):1976-89. PubMed ID: 19286669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
    Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
    Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
    Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
    PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and tissue-specific regulation of a novel dysferlin isoform.
    Salani S; Lucchiari S; Fortunato F; Crimi M; Corti S; Locatelli F; Bossolasco P; Bresolin N; Comi GP
    Muscle Nerve; 2004 Sep; 30(3):366-74. PubMed ID: 15318348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B.
    Bittel DC; Sreetama SC; Chandra G; Ziegler R; Nagaraju K; Van der Meulen JH; Jaiswal JK
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes.
    Cea LA; Bevilacqua JA; Arriagada C; Cárdenas AM; Bigot A; Mouly V; Sáez JC; Caviedes P
    BMC Cell Biol; 2016 May; 17 Suppl 1(Suppl 1):15. PubMed ID: 27229680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in sarcolemma repair and skeletal muscle function after injury in a mouse model of Niemann-Pick type A/B disease.
    Michailowsky V; Li H; Mittra B; Iyer SR; Mazála DAG; Corrotte M; Wang Y; Chin ER; Lovering RM; Andrews NW
    Skelet Muscle; 2019 Jan; 9(1):1. PubMed ID: 30611303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
    Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
    Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.